Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas P Shakespeare

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Oral Oncology|December 7, 2007
Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinomaJiade Jay Lu, Lin Kong, Thomas P Shakespeare, et al.
Journal of Medical Imaging and Radiation Oncology|January 21, 2016
Definitive intensity-modulated radiotherapy concurrent with systemic therapy for oropharyngeal squamous cell carcinoma: Outcomes from an integrated regional Australian cancer centreReza Masoud Rahbari, Lauren Winkley, Jacques Hill, et al.
Molecular and Clinical Oncology|July 19, 2021
Metaplastic carcinoma of the breast: Clinicopathological features and treatment outcomes with long-term follow upAron Gortman, Noel J Aherne, Justin Westhuyzen, et al.
ANZ Journal of Surgery|April 12, 2021
Survival outcomes for breast cancer patients who decline recommended treatment: a propensity score-matched analysisRashmi Shingde, Shehnarz Salindera, Noel J Aherne, et al.
Asia-Pacific Journal of Clinical Oncology|May 20, 2014
Prevalence of complementary and alternative therapy use by cancer patients undergoing radiation therapyGrace V Edwards, Noel J Aherne, Patrick J Horsley, et al.
Journal of Medical Radiation Sciences|September 21, 2016
Toxicity and dosimetric analysis of non-small cell lung cancer patients undergoing radiotherapy with 4DCT and image-guided intensity modulated radiotherapy: a regional centre's experienceGareth C Livingston, Andrew J Last, Thomas P Shakespeare, et al.
International Journal of Radiation Oncology, Biology, Physics|December 28, 2017
Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography for Prostate Cancer: Distribution of Disease and Implications for Radiation Therapy PlanningSandeep K Gupta, Tahne Watson, Jim Denham, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 3, 2008
Post-prostatectomy radiation therapy: consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary GroupMark A Sidhom, Andrew B Kneebone, Margot Lehman, et al.
International Journal of Radiation Oncology, Biology, Physics|November 23, 2006
The role of palliative radiation therapy in symptomatic locally advanced gastric cancerJeremy Tey, Michael F Back, Thomas P Shakespeare, et al.
Breast Cancer (Dove Medical Press)|May 17, 2023
Androgen Receptor Status in Triple Negative Breast Cancer: Does It Correlate with Clinicopathological Characteristics?Alex L Dubrava, Pan Su Pyae Kyaw, Joseph Newman, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Oral Oncology|December 7, 2007
Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinomaJiade Jay Lu, Lin Kong, Thomas P Shakespeare, et al.
Journal of Medical Imaging and Radiation Oncology|January 21, 2016
Definitive intensity-modulated radiotherapy concurrent with systemic therapy for oropharyngeal squamous cell carcinoma: Outcomes from an integrated regional Australian cancer centreReza Masoud Rahbari, Lauren Winkley, Jacques Hill, et al.
Molecular and Clinical Oncology|July 19, 2021
Metaplastic carcinoma of the breast: Clinicopathological features and treatment outcomes with long-term follow upAron Gortman, Noel J Aherne, Justin Westhuyzen, et al.
ANZ Journal of Surgery|April 12, 2021
Survival outcomes for breast cancer patients who decline recommended treatment: a propensity score-matched analysisRashmi Shingde, Shehnarz Salindera, Noel J Aherne, et al.
Asia-Pacific Journal of Clinical Oncology|May 20, 2014
Prevalence of complementary and alternative therapy use by cancer patients undergoing radiation therapyGrace V Edwards, Noel J Aherne, Patrick J Horsley, et al.
Journal of Medical Radiation Sciences|September 21, 2016
Toxicity and dosimetric analysis of non-small cell lung cancer patients undergoing radiotherapy with 4DCT and image-guided intensity modulated radiotherapy: a regional centre's experienceGareth C Livingston, Andrew J Last, Thomas P Shakespeare, et al.
International Journal of Radiation Oncology, Biology, Physics|December 28, 2017
Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography for Prostate Cancer: Distribution of Disease and Implications for Radiation Therapy PlanningSandeep K Gupta, Tahne Watson, Jim Denham, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 3, 2008
Post-prostatectomy radiation therapy: consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary GroupMark A Sidhom, Andrew B Kneebone, Margot Lehman, et al.
International Journal of Radiation Oncology, Biology, Physics|November 23, 2006
The role of palliative radiation therapy in symptomatic locally advanced gastric cancerJeremy Tey, Michael F Back, Thomas P Shakespeare, et al.
Breast Cancer (Dove Medical Press)|May 17, 2023
Androgen Receptor Status in Triple Negative Breast Cancer: Does It Correlate with Clinicopathological Characteristics?Alex L Dubrava, Pan Su Pyae Kyaw, Joseph Newman, et al.
Pageof 6